Test subheaderJanice Greenberg
Safe-T-Vue® 6 and 10 are the first (and currently only) blood temperature indicators to earn the AABB’s new ‘Standards-Compliant’ seal of approval.
An essential part of delivering quality patient care is making sure that medication remains within the appropriate temperature range to maintain its efficacy.
Learn how Safe-T-Vue 10 helps this mid-sized urban medical center to be advocates for patient safety when it comes to distributed transfusion.
Learn how TotalWellness minimized the risk of financial loss and product waste with immediate notification of temperature events using W-200 wireless monitoring.
On December 19, 2019, Temptime welcomed ‘VVM heroes’ and hosted a book signing for author Dr. Umit Kartoglu.
URAC v 4.0 has expanded on requirements around Performance Qualification (PQ) testing. Read more about the two key differences that may affect your medication shipment practices.
AON Pharmacy’s rapid growth and expansion into all 50 U.S. states compelled them to pursue PQ testing using Temptime’s EDGE PQ services – and quickly learned that their packouts were getting the job done.
As a key innovation required for the Controlled Temperature Chain (CTC) initiative, Temptime developed HEATmarker VVM+ specifically for monitoring heat stable vaccines.
Learn more about AON Pharmacy in this VUEPoint Case Study. Temptime’s temperature monitoring tools and procedures are supporting their mission to assure that patient medication is kept within its stability profile.
New Journal Article Documents the Performance of Two Blood Temperature Indicators in Real Hospital SettingJune 14th, 2019 by Janice Greenberg
An article recently published in Vox Sanguinis documents the performane testing of two temperature indicators, Safe-T-Vue 10 and Blood Temp 10.
Results presented in this White Paper highlight the need to select the appropriate temperature probe placement when performing the validation procedure so that the core blood bag temperature correlates to the actual temperature indicator performance.
Recent news in the United States about vaccines and an outbreak of measles in Washington has drawn national attention to the topic. Here we share an article from USA Today
This collection of articles focuses on the impact of “poor handling” on temperature-sensitive medications and biologic products in the hospital or pharmacy, during transport and in patients’ homes.